PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Flies model a potential sweet treatment for Parkinson's disease

Research presented at the Genetics Society of America's ongoing annual Drosophila Conference in Washington, D.C., suggests that mannitol, a sugar substitute, could lead to a future treatment for Parkinson's disease

2013-04-06
(Press-News.org) Washington, D.C. – (April 6, 2013) — Researchers from Tel Aviv University describe experiments that could lead to a new approach for treating Parkinson's disease (PD) using a common sweetener, mannitol. This research is presented today at the Genetics Society of America's 54th Annual Drosophila Research Conference in Washington D.C., April 3-7, 2013.

Mannitol is a sugar alcohol familiar as a component of sugar-free gum and candies. Originally isolated from flowering ash, mannitol is believed to have been the "manna" that rained down from the heavens in biblical times. Fungi, bacteria, algae, and plants make mannitol, but the human body can't. For most commercial uses it is extracted from seaweed although chemists can synthesize it. And it can be used for more than just a sweetener.

The Food and Drug Administration approved mannitol as an intravenous diuretic to flush out excess fluid. It also enables drugs to cross the blood-brain barrier (BBB), the tightly linked cells that form the walls of capillaries in the brain. The tight junctions holding together the cells of these tiniest blood vessels come slightly apart five minutes after an infusion of mannitol into the carotid artery, and they stay open for about 30 minutes.

Mannitol has another, less-explored talent: preventing a sticky protein called α-synuclein from gumming up the substantia nigra part of the brains of people with PD and Lewy body dementia (LBD), which has similar symptoms to PD. In the disease state, the proteins first misfold, then form sheets that aggregate and then extend, forming gummy fibrils.

Certain biochemicals, called molecular chaperones, normally stabilize proteins and help them fold into their native three-dimensional forms, which are essential to their functions. Mannitol is a chemical chaperone. So like a delivery person who both opens the door and brings in the pizza, mannitol may be used to treat Parkinson's disease by getting into the brain and then restoring normal folding to α-synuclein.

Daniel Segal, PhD, and colleagues at Tel Aviv University investigated the effects of mannitol on the brain by feeding it to fruit flies with a form of PD that has highly aggregated α-synuclein.

The researchers used a "locomotion climbing assay" to study fly movement. Normal flies scamper right up the wall of a test tube, but flies whose brains are encumbered with α-synuclein aggregates stay at the bottom, presumably because they can't move normally. The percentage of flies that climb one centimeter in 18 seconds assesses the effect of mannitol.

An experimental run tested flies daily for 27 days. After that time, 72% of normal flies climbed up, in comparison to 38% of the PD flies. Their lack of ascension up the sides of the test tube indicated "severe motor dysfunction."

In contrast, were flies bred to harbor the human mutant α-synuclein gene, who as larvae feasted on mannitol that sweetened the medium at the bottoms of their vials. These flies fared much better -- 70% of them could climb after 27 days. And slices of their brains revealed a 70% decrease in accumulated misfolded protein compared to the brains of mutant flies raised on the regular medium lacking mannitol.

It's a long way from helping climbing-impaired flies to a new treatment for people, but the research suggests a possible novel therapeutic direction. Dr. Segal, however, cautioned that people with PD or similar movement disorders should not chew a ton of mannitol-sweetened gum or sweets; that will not help their current condition. The next step for researchers is to demonstrate a rescue effect in mice, similar to improved climbing by flies, in which a rolling drum ("rotarod") activity assesses mobility.

"Until and if mannitol is proven to be efficient for PD on its own, the more conservative and possibly more immediate use can be the conventional one, using it as a BBB disruptor to facilitate entrance of other approved drugs that have problems passing through the BBB," Dr. Segal said. A preliminary clinical trial of mannitol on a small number of volunteers might follow if results in mice support those seen in the flies, he added, but that is still many research steps away.

Session Title: Drosophila Models of Human Diseases I
Program #91 -- Date and Time: Saturday, April 6, 2013; 8:30-8:45 AM
Location: Marriott Wardman Park, Marriott Ballroom Salon 1, Lobby Level
Mannitol ¬-- a BBB disrupter is also a potent α-synuclein aggregation inhibitro for treating Parkinson's disease. Daniel Segal1,2, Ronit Shaltiel-Karyo1, Moran Frenkel-Pinter1, Edward Rockenstein3, Christina Patrick3, Michal Levy-Sakin1, Nirit Egoz-Matia1, Eliezer Masliah3, Ehud Gazit1. 1) Department of Molecular Microbiol & Biotech, Tel Aviv University, Tel Aviv 69978, Israel; 2) Sagol School of Neurosciences, Tel Aviv University, Tel Aviv 69978, Israel; 3) Department of Neurosciences, School of Medicine, University of California at San Diego, La Jolla, CA 92093, USA.

INFORMATION:

FOR MEMBERS OF THE MEDIA: The 54th Annual Drosophila Research Conference is open to print, online and broadcast news media and freelance science, medical and health writers on a verifiable assignment from an established news source. If you would like to attend all or part of the Conference, complimentary meeting registration is available to members of the media who provide appropriate press credentials and identification. Please contact: Phyllis Edelman, GSA Communications and Public Relations Manager, pedelman@genetics-gsa.org, or phone: 301-351-0896.

ABOUT THE GSA DROSOPHILA RESEARCH CONFERENCE: Nearly 1,500 researchers attend the annual GSA Drosophila Research Conference to share the latest research using the fruit fly Drosophila melanogaster and other insect species. Many of findings from these model organisms have broad application for the study of human genetic traits and diseases. For more information about the conference, see http://www.dros-conf.org/2013/

ABOUT GSA: Founded in 1931, the Genetics Society of America (GSA) is the professional membership organization for scientific researchers, educators, bioengineers, bioinformaticians and others interested in the field of genetics. Its nearly 5,000 members work to advance knowledge in the basic mechanisms of inheritance, from the molecular to the population level. The GSA is dedicated to promoting research in genetics and to facilitating communication among geneticists worldwide through its conferences, including the biennial conference on Model Organisms to Human Biology, an interdisciplinary meeting on current and cutting edge topics in genetics research, as well as annual and biennial meetings that focus on the genetics of particular organisms, including C. elegans, Drosophila, fungi, mice, yeast, and zebrafish. GSA publishes GENETICS, a leading journal in the field and a new online, open-access publication, G3: Genes|Genomes|Genetics. For more information about GSA, please visit http://www.genetics-gsa.org. Also follow GSA on Facebook at facebook.com/GeneticsGSA and on Twitter @GeneticsGSA.

END



ELSE PRESS RELEASES FROM THIS DATE:

Barrow researchers identify new vision of how we explore our world

2013-04-06
(Phoenix, AZ April 4, 2013) -- Brain researchers at Barrow Neurological Institute have discovered that we explore the world with our eyes in a different way than previously thought. Their results advance our understanding of how healthy observers and neurological patients interact and glean critical information from the world around them. The research team was led by Dr. Susana Martinez-Conde, Director of the Laboratory of Visual Neuroscience at Barrow, in collaboration with fellow Barrow Neurological Institute researchers Jorge Otero-Millan, Rachel Langston, and Dr. ...

Highly lethal Ebola virus has diagnostic Achilles' heel for biothreat detection, scientists say

2013-04-06
By screening a library of a billion llama antibodies on live Ebola viruses in the Texas Biomedical Research Institute's highest biocontainment laboratory, scientists in San Antonio have identified a potential weakness in the make-up of these deadly agents that can immediately yield a sensitive test. "Detecting single viral protein components can be challenging, especially at very low levels. However, most viruses are repetitive assemblies of a few components, called antigens, with some existing as polymers which present highly 'avid' targets for antibodies," said Texas ...

Treatments, not prevention, dominate diabetes research

2013-04-06
DURHAM, NC – Research for diabetes is far more focused on drug therapies than preventive measures, and tends to exclude children and older people who have much to gain from better disease management, according to a Duke Medicine study. By analyzing nearly 2,500 diabetes-related trials registered in ClinicalTrials.gov from 2007-10, the authors provide a broad overview of the research landscape for diabetes. The effort is part of the Clinical Trials Transformation Initiative, a public-private partnership founded by the U.S. Food and Drug Administration (FDA) and Duke University ...

Diabetes trials worldwide are not addressing key issues in affected populations

2013-04-06
An analysis of diabetes trials worldwide has found they are not addressing key issues relating to the condition with almost two thirds focusing on drug therapy while only one in ten addresses prevention or behavioural therapies. The research is published in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD), and is by Dr Jennifer Green, Duke University Medical Center, Durham, NC, USA, and colleagues. There are an estimated 371 million people with diabetes in the world. By 2030, there will be some 550 million with diabetes based on current ...

Huge disparities in hypertension seen across US counties

2013-04-06
SEATTLE – One in five Americans are completely unaware that they are at risk for the second leading cause of premature death: high blood pressure. In the first ever analysis of awareness, treatment, and control of hypertension for every county, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington revealed significant differences across the US. The study found the largest burden of hypertension in the southeast, the lowest prevalence in Colorado, and differences among genders, ethnic groups and geographies. But despite high prevalence ...

Electron conflict leads to 'bad traffic' on way to superconductivity

2013-04-06
HOUSTON -- (April 5, 2013) -- Rice University physicists on the hunt for the origins of high-temperature superconductivity have published new findings this week about a seemingly contradictory state in which a material simultaneously exhibits the conflicting characteristics of both a metallic conductor and an insulator. In a theoretical analysis this week in Physical Review Letters (PRL), Rice physicists Qimiao Si and Rong Yu offer an explanation for a strange series of observations described earlier this year by researchers at the Stanford Linear Accelerator ...

Stem cells enable personalized treatment for bleeding disorder

2013-04-06
Scientists have shed light on a common bleeding disorder by growing and analysing stem cells from patients' blood to discover the cause of the disease in individual patients. The technique may enable doctors to prescribe more effective treatments according to the defects identified in patients' cells. In future, this approach could go much further: these same cells could be grown, manipulated, and applied as treatments for diseases of the heart, blood and circulation, including heart attacks and haemophilia. The study focused on von Willebrand disease (vWD), which ...

Liver transplantation for patients with genetic liver conditions has high survival rate

2013-04-06
Chicago (April 5, 2013): Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases. Among the main considerations are the anxiety of waiting for a donor organ, the risks associated with the transplant operation, and the chance that the transplant procedure will not achieve the desired result. There is also the six-figure cost of the procedure and accompanying patient care, all of which may not be completely covered by health ...

SFU researchers help unlock pine beetle's Pandora's box

2013-04-06
Twenty researchers — more than half of them Simon Fraser University graduates and/or faculty — could become eastern Canada's knights in shining white lab coats. A paper detailing their newly created sequencing of the mountain pine beetle's (MPB) genome will be gold in the hands of scientists trying to stem the beetle's invasion into eastern forests. The journal Genome Biology has published the paper. "We know a lot about how beetle infestations can devastate forests, just as the mountain pine beetle has been doing to B.C.'s lodgepole pines," says Christopher Keeling, ...

Experts call for research on prevalence of delayed neurological dysfunction after head injury

2013-04-06
One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury (TBI). Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI. About one percent of the population in the developed world has experienced TBI, which can cause serious long-term ...

LAST 30 PRESS RELEASES:

Safflower yellow pigments in coronary heart disease: Mechanisms, applications, and future perspectives

TraMA: new RNA-based measure predicts mortality risk and tracks aging

From WebMD to AI chatbots: How innovation has empowered patients to take control of their health

Unravelling antileishmanial mechanisms of phytochemicals: From mitochondrial disruption to immunomodulation

Association for Molecular Pathology announces 2025 award recipients

When light collides with light

Study finds that white students visit college advisers the least, but benefit most in terms of graduation rates and GPA

Science by the millions: How everyday people are revolutionizing global biodiversity research with tech

A bolt is born! Atmospheric events underpinning lightning strikes explained

Using alcohol to reduce the costs of industrial water electrolysis

FAU researchers advise: prescribe high potency statins in treatment, prevention

15 regions chosen for groundbreaking effort to reduce cardiovascular disease

CareQuest Institute for Oral Health to fund year six of the AADOCR Mind the Future Program

Chungnam National University researchers reveal how vitamin D is shown to reduce liver damage by boosting TXNIP activity in cholangiocytes

The key to success: Why university startups don’t perform as well as corporate startups

Muscle “marbling”: Good in steak, bad in our bodies

Thousands more B.C. women chose top-tier birth control after patient costs eliminated

Research reveals genetic weak spot in hard-to-treat cancers

Coolness hits different; now scientists know why

Large-scale study defines genetic architecture of stuttering

Decoding the blue: Advanced Technology realizes potential in harmful algal bloom monitoring

How plants are learning to spot sneaky bacterial invaders

One in 11 older Canadians has experienced depression, University of Toronto study finds

VR nature scenes reduce sensitivity to pain – especially for those who feel present during the experience

Canadian health data security is critical in changing political climate

Helping Canada lead in health innovation

Virtual care network for rural and First Nations communities

Dementia takes 3.5 years to diagnose after symptoms begin

Robotic space rovers keep getting stuck. UW engineers have figured out why

New research shows how immigration status can become a death sentence during public health crisis

[Press-News.org] Flies model a potential sweet treatment for Parkinson's disease
Research presented at the Genetics Society of America's ongoing annual Drosophila Conference in Washington, D.C., suggests that mannitol, a sugar substitute, could lead to a future treatment for Parkinson's disease